
3. Wang B, Zhang J, Han W, Tang X, Tian F. Incidence and risk factors of infection
after fracture fixation: A multicenter cohort study. Orthopaedic Surgery.
2025;17(1):151-162. doi:10.1111/os.14278.
4. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
The PRISMA 2020 statement: An updated guideline for reporting systematic
reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
5. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
PRISMA 2020 explanation and elaboration: Updated guidance and exemplars
for reporting systematic reviews. BMJ. 2021;372:n160.
6. Metsemakers WJ, Morgenstern M, Senneville E, Borens O, Govaert GAM, Onsea J,
et al. Fracture-related infection: A consensus on definition from an international
expert group. Injury. 2018;49(3):505-510. doi:10.1016/j.injury.2017.08.040.
7. McNally M, Govaert G, Dudareva M, Morgenstern M, Metsemakers WJ. Definition
and diagnosis of fracture-related infection. EFORT Open Reviews.
2020;5(10):614-619. doi:10.1302/2058-5241.5.190072.
8. Metsemakers WJ, Kuehl R, Moriarty TF, Richards RG, Verhofstad MHJ, Borens O,
et al. General treatment principles for fracture-related infection:
Recommendations from an international expert group. Archives of Orthopaedic
and Trauma Surgery. 2020;140(8):1013-1027. doi:10.1007/s00402-019-03287-4.
9. Depypere M, Kuehl R, Metsemakers WJ, Senneville E, McNally MA, Obremskey
WT, et al. Recommendations for systemic antimicrobial therapy in
fracture-related infection: A consensus from an international expert group.
Journal of Orthopaedic Trauma. 2020;34(1):30-41.
doi:10.1097/BOT.0000000000001626.